Medico-Economic Contribution of Multiplex PCR To the Diagnosis of Meningitis

Author(s)

Mansouri K1, Benali L2, Neghmouche Ali I1, Abdalli I3, Oulmane N3, Yala A3
1University of Algiers 1, faculty of pharmacy, Algiers, Algeria, 2University of Algiers 1, faculty of pharmacy, Algiers, 16, Algeria, 3Access Focus, Algiers, Algeria

OBJECTIVES: Meningitis is a serious infection that affects the central nervous system with an incidence of 10,76 cases per 100 000 inhabitants in Algeria. The constraints encountered when using conventional diagnostic methods (CDMs) for meningitis have led to developing new diagnostic methods, including multiplex PCR (MPCR). The aim was to evaluate the medico-economic contribution of MPCR compared with CDMs.

METHODS: A Medico-economic modelling was established over five-years, showing comparative costs between MPCR and CDMs in three scenarios considered when simplex-PCR detected the pathogenic germ: from the 1st test (best case), 4th test (base case), 7th test (worst case) knowing that MPCR can detect six bacteria, seven viruses and one fungus simultaneously. This model is based on results obtained from a hospital laboratory that has been extrapolated to the Algerian population. The data were based on the public and private sectors. After describing the conventional and the new MPCR diagnostic methods, we calculated the costs of a bacteriological examination of cerebrospinal fluid, simplex-PCR and MPCR tests.

RESULTS: 359 cases were examined in the hospital laboratory. When comparing conventional diagnostic and MPCR methods, MPCR was more expensive than CDMs in best case. However, in base and worst cases, MPCR were less expensive.

The estimated population with meningitis is 4927 people in the first year. A minor increase in the cumulative incremental budget has been observed in the first scenario. However, in 2nd and 3rd scenarios, MPCR have generated significant savings of more than 1,417,366$ and 3,242,796$ respectively over the five years.

CONCLUSIONS: The comparison between CDMs and MPCR highlights the advantages of this one despite its initial cost. In addition, MPCR reduces the time taken to make a diagnosis, decreasing duration and hospitalization-cost and leading to the appropriate use of antibiotics. This enables early therapeutic adaptation, which influences the patient journey and avoids antibiotic resistance.

Conference/Value in Health Info

2024-05, ISPOR 2024, Atlanta, GA, USA

Value in Health, Volume 27, Issue 6, S1 (June 2024)

Code

EE55

Topic

Economic Evaluation, Medical Technologies

Topic Subcategory

Budget Impact Analysis, Diagnostics & Imaging, Medical Devices

Disease

Infectious Disease (non-vaccine), Medical Devices

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×